Snowball logo
logo
4559_logo

Zeria Pharmaceutical Co Ltd

4559 TSE
¥2,085.00+¥7.00  (0.34%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
59,532.868,383.275,725.187,311.189,159.391,118
COGS
17,384.623,265.825,543.829,201.523,976.624,615.1
Gross Profit
42,148.345,117.450,181.358,109.665,182.666,502.9
Operating Expenses & Income
Operating Income
6,366.19,0159,716.612,197.612,374.412,804.7
Total Operating Expenses
35,782.236,102.440,464.745,91252,808.253,698.2
R&D Expenses
4,789.33,456.13,726.94,106.7--
Selling General & Admin Expenses
27,44728,26731,54436,156--
Earnings from Continuing Operations
Interest Expense
(315.5)(337.3)(457.8)(452.3)(501.8)(512)
Interest Income
421.41,437.4150.9282.9111.8-
Income Tax Expense
1,7471,065.91,813.22,650.62,7832,705.9
Net Income
Net Income
3,961.26,195.97,731.39,936.38,454.58,230
Supplemental
EBIT
6,366.19,0159,716.612,197.612,374.412,804.7
EBITDA
11,766.615,163.217,272.119,752.319,721.620,691.8
In millions of JPY, except % and values per 1 share